Skip to main content

Table 1 Baseline characteristics of the Sinikithemba paediatric cohort

From: Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa

Demography [n (%)]
Children 151
Female 77 (51.0%)
Age  
   < 3 years 39 (25.8%)
   3–5 years 43 (28.5%)
   6–8 years 43 (28.5%)
   ≥ 9 years 26 (17.2%)
   Median years [range] 5.7 [.3–15.4]
Parent status [n (%)]
   Two parents alive 67 (44.4%)
   Only father living 19 (12.6%)
   Only mother living 27 (17.9%)
   Neither parent living 38 (25.1%)
WHO clinical stage [n (%)] [n (%)]
   Stage 1 26 (17.2%)
   Stage 2 19 (12.6%)
   Stage 3 72 (47.7%)
   Stage 4 34 (22.5%)
Anthropometry Median (IQR)
   Weight-for-age Z-score -1.9 (-3.6 to -0.9)
   Height-for-age Z-score -2.2 (-3.0 to -1.1)
CD4 lymphocyte % [n (%)]
   < 5% 52 (35.6%)
   5%-9% 36 (24.7%)
   10%-14% 28 (19.2%)
   15%-24% 26 (17.8%)
   > 25% 4 (2.7%)
   Median CD4% (IQR) 7.4 (2.1–13.7)
Laboratory values Median (IQR)
   Albumin (g/L) 30.0 (26.0–35.0)
   ALT (IU/L) 18.0 (14.0–28.3)
   Hemoglobin (g/dl) 10.1 (8.9–11.0)
Tuberculosis [n (%)]
   Present 50 (33.1%)
Other opportunistic infections [n (%)]
   Chronic gastroenteritis 52 (34.4%)
   Pneumonia 13 (8.6%)
   Oesophageal candidiasis 13 (8.6%)
   PCP 11 (7.3%)
   Cryptococcal meningitis 1 (0.7%)
   CMV retinitis 0
   Toxoplosmosis 0